Semaglutide
Also known as Ozempic, Wegovy, Rybelsus, made by Novo Nordisk
Quick facts
- Researched for
- Appetite control, less food noise, weight loss, belly fat and glucose control
- Route or form
- Injection
- Evidence so far
- Human trials show weight loss and lower blood sugar; joint relief rests on forum posts.
- Not established
- Approved drug results do not prove a non-prescription version is well made or works.
- Commonly researched
- Starts at 0.25 mg, once weekly, then steps upPrescription label (branded medicine)See every range
- Where to get it
- Ozempic, Wegovy and Rybelsus are prescription medicines. A doctor prescribes them and a pharmacy fills them.Our partner, US Precision Peptides, lists a separate semaglutide product, not those medicines.Go to Next step
By the Learn Peptides editorial team · Updated · How We Research
What people are researching it for
People are researching semaglutide for appetite control, less , weight loss, belly fat, and glucose control.
Less noise. More progress.
- What is Semaglutide?
- Checklist: Long-acting (weekly)
- How does it work?
- Not written out in this text version.
- Common research use cases
- Many of these uses are research-based or off-label. Individual responses vary.
- How it's used in research
- Route: Subcutaneous injection (once weekly)
- Common dosing: Start low, go slow
- Common dosing: Once weekly injection
- Common dosing: Dose adjusted over time
- Common dosing: Long-term use often needed
- Often combined with: Nutrition and exercise
- Often combined with: Healthy lifestyle habits
- Often combined with: Regular monitoring
- Often combined with: Professional guidance
- There is no standardized dose or protocol. Research use should be thoughtful, tracked, and adjusted based on individual response.
- What users report
- Keep in mind: Results vary widely
- Keep in mind: GI side effects are common, especially early on
- Keep in mind: Weight loss is not linear
- Keep in mind: Stopping often leads to weight regain
- Key takeaway
- It's not a quick fix, and it works best as part of a broader plan. Like any peptide or medication, it has potential side effects and isn't right for everyone.
- The bottom line
- Semaglutide shows strong potential for weight management and metabolic health, with additional promising effects on blood sugar, cardiovascular markers, and even alcohol cravings. Use only high-quality peptides, follow a conservative approach, and work with a knowledgeable professional to determine if it's right for your goals.
Reasons people look into Semaglutide. An interest is not a promise that it works.
- Injury & recovery
- Weight loss & metabolic
People often say food noise and hunger ease, with stomach upset and fatigue.
Community reports
A common report is that food takes up less mental space and appetite feels easier to manage. Stomach side effects and fatigue are also common.
Community reports
People on semaglutide consistently describe their appetite and constant thoughts about food going quiet, which makes it easier to eat less without feeling like they're fighting themselves. Many also report drinking less alcohol, along with stomach side effects, hair thinning, and a stretch where hunger creeps back and pushes them toward a higher dose.
Large human trials of approved semaglutide show weight loss, less hunger and better blood sugar.
Large human trials show weight loss, lower appetite, better glucose control, and less visceral fat with approved semaglutide medicines.
The medicine that made appetite suppression mainstream: it quiets the constant background noise about food so eating less stops feeling like a fight.
What this is based on
- Human researchStudied in people for this or a related question.
- Community reportsWhat people describe noticing. Not proof of cause.
- Learn Peptides explanationOur own plain-English summary of the sources. It is not a source itself.
Approved drug results do not prove a non-prescription version is well made or works.
Results from approved medicines do not establish the quality or performance of a separate, non-prescription version.
Safety notes
Tested in people. How many took part, for how long, and who they were still matter.
- You have trouble breathing or wheezing, or your face, lips, tongue or throat swell.
- You get hives away from the injection site, or feel severely dizzy or faint.
For these signs, call 911 or your local emergency number.
- You have severe stomach pain that does not go away, with or without vomiting. It may spread to your back. Stop it and get medical help now. Its label lists this as a sign of pancreatitis. Wegovy label and Medication Guide (FDA, via DailyMed) (opens in a new tab)
- You notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Its label lists these as possible signs of thyroid cancer. Wegovy label and Medication Guide (FDA, via DailyMed) (opens in a new tab)
- You have pain in your upper stomach, a fever, yellow skin or eyes, or clay-colored stools. Its label lists these as possible signs of gallbladder problems. Wegovy label and Medication Guide (FDA, via DailyMed) (opens in a new tab)
- You also take insulin or other blood-sugar medicine and feel dizzy, shaky, sweaty, confused or drowsy, or your heart beats fast. Its label lists these as signs of low blood sugar. Wegovy label and Medication Guide (FDA, via DailyMed) (opens in a new tab)
- Redness spreads, or heat, swelling or pain keeps growing where you injected.
- A lump keeps growing or does not go away, or you see pus or red streaks.
- You have a fever or chills, or feel sick all over.
- Medullary thyroid cancer or MEN2 (you or your family). Its label carries a boxed warning against use with a personal or family history of medullary thyroid cancer or MEN2.
- Pancreatitis or gallbladder disease. Its label warns about pancreatitis and gallbladder problems. With a history of either, this is one to talk through with your doctor first.
- Diabetes, or you take insulin or blood-sugar medicine. Combined with insulin or other blood-sugar medicine it can push blood sugar too low. Your doctor may need to adjust those medicines.
Questions to bring to your doctor
Only for the conditions this page cautions about. Bring this page with you.
- I or someone in my family has had medullary thyroid cancer or MEN2. Does that rule out semaglutide for me?
- I have had pancreatitis or gallbladder problems. Is semaglutide a concern for me?
- Would my insulin or blood-sugar medicine need to change if I used semaglutide?
Shows the Wegovy and Ozempic label amounts, kept apart from what people report.
Commonly researched ranges, and how they were measured.
Commonly researched range for Semaglutide
Starting dose
0.25 mg
once weekly · Injection
Prescription label (branded medicine)
This is the label amount for the branded medicine Wegovy. It is not a dosing instruction for other products.
How the dose steps up
Each schedule comes from one source, shown in order. Do not mix steps from different sources.
Wegovy label (branded medicine)
- Step 1 of 3: Weeks 1 to 40.25 mg once weekly
- Step 2 of 3: ThenSteps up every 4 weeks, following the label’s own table
- Step 3 of 3: Maintenance1.7 to 2.4 mg once weekly
The label starts low to reduce stomach side effects. These are label amounts for the branded medicine. They are not dosing instructions for other products.
Ozempic label (type 2 diabetes)
- Step 1 of 3: Weeks 1 to 40.25 mg once weekly, a starting step and not a treatment dose
- Step 2 of 3: ThenSteps up, with at least 4 weeks at each step
- Step 3 of 3: Maintenance0.5 to 2 mg once weekly
These are label amounts for the branded medicine. They are not dosing instructions for other products.
All 4 ranges in our record
Each one is labeled with where it comes from. Some are parts of the step-up schedules above. Do not mix steps from different sources.
Escalation start
Prescription label (branded medicine)FDA label (Wegovy)- Amount per dose
- 0.25 mg
- How often
- Once weekly
- Typical schedule
- 4 weeks at each step before increasing, per label Table 1
- Route
- Injection
This is the label amount for the branded medicine Wegovy. It is not a dosing instruction for other products.
Maintenance
Prescription label (branded medicine)FDA label (Wegovy)- Amount per dose
- 1.7 to 2.4 mg
- How often
- Once weekly
- Typical schedule
- Not stated
- Route
- Injection
This is the label amount for the branded medicine Wegovy. It is not a dosing instruction for other products.
Maintenance, lower end
Prescription label (branded medicine)FDA label (Ozempic, type 2 diabetes cross-reference)- Amount per dose
- 0.5 to 1 mg
- How often
- Once weekly
- Typical schedule
- Starts at 0.25 mg/week for 4 weeks (not a treatment dose), then steps up every 4+ weeks
- Route
- Injection
This is the label amount for the branded medicine Ozempic. It is not a dosing instruction for other products.
Maintenance, upper end
Prescription label (branded medicine)FDA label (Ozempic, type 2 diabetes cross-reference)- Amount per dose
- 1 to 2 mg
- How often
- Once weekly
- Typical schedule
- Starts at 0.25 mg/week for 4 weeks (not a treatment dose), then steps up every 4+ weeks
- Route
- Injection
This is the label amount for the branded medicine Ozempic. It is not a dosing instruction for other products.
From our visual summary
Community reports
Community reports, from the Learn Peptides visual summary. These lines sit beside the ranges above and are not merged with them.
- Common dosing
- Start low, go slow
- Once weekly injection
- Dose adjusted over time
- Long-term use often needed
There is no standard dose. Track how you respond, and change one thing at a time.
These ranges were last reviewed Sep 2026.
Novo Nordisk's medicine in Ozempic and Wegovy, first FDA-approved in 2017 for type 2 diabetes.
Semaglutide is sold as Ozempic and Wegovy (and as a pill, Rybelsus), made by Novo Nordisk. It was developed for type 2 diabetes, and the first approved it in 2017 to lower blood sugar (as Ozempic). It was approved separately in 2021 for weight management (as Wegovy), once its appetite effects turned out to be dramatic. It's given as an injection.
Three weekly injections studied for weight loss. They act on 1, 2 or 3 hormone signals. Here is what people report, what trials show and what is still unknown.
Next step
US Precision Peptides
This US Precision Peptides listing is a separate product, not the brand-name medicines Ozempic or Wegovy or Rybelsus from Novo Nordisk. Check the listing’s own formulation, labeled use and purchase requirements.
About product links
Purchases at US Precision Peptides help keep Learn Peptides free.